BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 26657902)

  • 1. Mode of Delivery among HIV-Infected Pregnant Women in Philadelphia, 2005-2013.
    Thompson DR; Momplaisir FM; Adams JW; Yehia BR; Anderson EA; Alleyne G; Brady KA
    PLoS One; 2015; 10(12):e0144592. PubMed ID: 26657902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000-2010.
    Briand N; Jasseron C; Sibiude J; Azria E; Pollet J; Hammou Y; Warszawski J; Mandelbrot L
    Am J Obstet Gynecol; 2013 Oct; 209(4):335.e1-335.e12. PubMed ID: 23791563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006.
    Townsend CL; Cortina-Borja M; Peckham CS; de Ruiter A; Lyall H; Tookey PA
    AIDS; 2008 May; 22(8):973-81. PubMed ID: 18453857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.
    Kowalska A; Niemiec T; El Midaoui A; Burkacka E
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):459-68. PubMed ID: 15010556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.
    Joao EC; Gouvêa MI; Menezes JA; Sidi LC; Cruz ML; Berardo PT; Ceci L; Cardoso CA; Teixeira Mde L; Calvet GA; Matos HJ
    Int J STD AIDS; 2012 Jan; 23(1):44-7. PubMed ID: 22362687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
    Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
    BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
    Read PJ; Mandalia S; Khan P; Harrisson U; Naftalin C; Gilleece Y; Anderson J; Hawkins DA; Taylor GP; de Ruiter A;
    AIDS; 2012 Jun; 26(9):1095-103. PubMed ID: 22441248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed opportunities among HIV-positive women to control viral replication during pregnancy and to have a vaginal delivery.
    Aebi-Popp K; Mulcahy F; Glass TR; Rudin C; Martinez de Tejada B; Bertisch B; Fehr J; Grawe C; Scheibner K; Rickenbach M; Hoesli I; Thorne C; ;
    J Acquir Immune Defic Syndr; 2013 Sep; 64(1):58-65. PubMed ID: 23842074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT?
    Tenthani L; van Oosterhout JJ; Haas AD; Msukwa M; Phiri N; Chimbwandira F; Tal K; Aebi-Popp K; Estill J; Keiser O
    BMC Pregnancy Childbirth; 2018 Apr; 18(1):95. PubMed ID: 29649980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
    Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
    Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
    Tubiana R; Mandelbrot L; Le Chenadec J; Delmas S; Rouzioux C; Hirt D; Treluyer JM; Ekoukou D; Bui E; Chaix ML; Blanche S; Warszawski J;
    Clin Infect Dis; 2013 Sep; 57(6):891-902. PubMed ID: 23766338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of short-course antenatal antiretroviral therapy on viral load and mother-to-child transmission in subsequent pregnancies among HIV-infected women.
    French CE; Tookey PA; Cortina-Borja M; de Ruiter A; Townsend CL; Thorne C
    Antivir Ther; 2013; 18(2):183-92. PubMed ID: 23475123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of mode of delivery and predictors of emergency caesarean section among women living with HIV in a matched-pair setting with women from the general population in Denmark, 2002-2014.
    Ørbaek M; Thorsteinsson K; Helleberg M; Moseholm E; Katzenstein TL; Storgaard M; Johansen IS; Pedersen G; Weis N; Lebech AM
    HIV Med; 2017 Nov; 18(10):736-747. PubMed ID: 28544321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa.
    Myer L; Phillips TK; McIntyre JA; Hsiao NY; Petro G; Zerbe A; Ramjith J; Bekker LG; Abrams EJ
    HIV Med; 2017 Feb; 18(2):80-88. PubMed ID: 27353189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point-of-care HIV viral load in pregnant women without prenatal care: a cost-effectiveness analysis.
    Avram CM; Greiner KS; Tilden E; Caughey AB
    Am J Obstet Gynecol; 2019 Sep; 221(3):265.e1-265.e9. PubMed ID: 31229430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
    Mandelbrot L; Tubiana R; Le Chenadec J; Dollfus C; Faye A; Pannier E; Matheron S; Khuong MA; Garrait V; Reliquet V; Devidas A; Berrebi A; Allisy C; Elleau C; Arvieux C; Rouzioux C; Warszawski J; Blanche S;
    Clin Infect Dis; 2015 Dec; 61(11):1715-25. PubMed ID: 26197844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.
    European Collaborative Study
    Clin Infect Dis; 2005 Feb; 40(3):458-65. PubMed ID: 15668871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study.
    Katz IT; Leister E; Kacanek D; Hughes MD; Bardeguez A; Livingston E; Stek A; Shapiro DE; Tuomala R
    Ann Intern Med; 2015 Jan; 162(2):90-9. PubMed ID: 25599347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnancy complications in HIV-positive women: 11-year data from the Frankfurt HIV Cohort.
    Reitter A; Stücker AU; Linde R; Königs C; Knecht G; Herrmann E; Schlößer R; Louwen F; Haberl A
    HIV Med; 2014 Oct; 15(9):525-36. PubMed ID: 24602285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.